Integrative Oncology in the United States: Memorial Sloan-Kettering Cancer Center programme as prototype

By Cassileth B.  

Psycho-Oncologie, Vol. 5, Iss. 3, 2011-09 ,pp. : 152-156

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel - The Memorial Sloan-Kettering Cancer Center experience

By Dizon D.S.   Dupont J.   Anderson S.   Sabbatini P.   Hummer A.   Aghajanian C.   Spriggs D.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 584-590

Elsevier

Access to resources Recommend Favorite

The high-risk prostate cancer patient

By Hussain M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 211-211

Elsevier

Access to resources Recommend Favorite

Lung cancer susceptibility: are we on our way to identifying a high-risk group?

By Kiyohara Chikako   Yoshimasu Kouichi   Takayama Koichi   Nakanishi Yoichi  

Future Oncology, Vol. 3, Iss. 6, 2007-12 ,pp. : 617-627

Future Medicine

Access to resources Recommend Favorite

Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy

By Cheung R.   Tucker S.L.   Dong L.   Kuban D.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 56, Iss. 5, 2003-08 ,pp. : 1234-1240

Elsevier

Access to resources Recommend Favorite